BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW

Clinical trials for BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW explained in plain language.

Never miss a new study

Get alerted when new BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW trials appear

Sign up with your email to follow new studies for BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a simple drug combo reverse jaw bone damage from common medications?

Disease control Ongoing

This study tests whether a combination of two drugs (pentoxifylline and tocopherol, a form of vitamin E) can help heal jaw bone damage caused by medications for osteoporosis or cancer. About 100 adults with this condition will receive either the drug combo plus standard care, or …

Matched conditions: BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW

Phase: PHASE3 • Sponsor: University of Washington • Aim: Disease control

Last updated May 08, 2026 12:02 UTC

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW

Get alerted when new BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW trials appear

Could a simple drug combo reverse jaw bone damage from common medications?